What is the current Eliquis market size?

The Eliquis market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Eliquis market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Eliquis market?

Increasing demand for anticoagulants and rising awareness of stroke prevention drive the market.

What are the challenges facing the Eliquis market?

Stringent regulations and competition from generic drugs pose significant challenges.

Which regions are leading the Eliquis market?

North America and Europe are the regional leaders due to high adoption rates.

Who are the top companies in the Eliquis market?

Bristol Myers Squibb and Pfizer are the leading companies in the market.

What future opportunities exist in the Eliquis market?

Emerging markets and innovative technologies offer future outlook opportunities.

How does technology impact the Eliquis market?

Advances in technology improve drug development and patient outcomes in the market.

What is the regulatory landscape for the Eliquis market?

Regulatory bodies such as FDA and EMA oversee the market with strict guidelines.

What is the future outlook for the Eliquis market?

The market is expected to grow steadily due to increasing demand and innovation.

How Big Is the Eliquis Market? Size, Share & Forecast 2033

Eliquis by Type (2.5 mg, 5 mg, World Eliquis Production), by Application (Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Others, World Eliquis Production), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 73

Forecast Period: 2026 - 2033

Market Size: $13000 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 73

Forecast Period: 2026 - 2033

Market Size: $13000 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Eliquis Market Size | CAGR 10.2 Forecast 2033

How Big Is the Eliquis Market? Size, Share & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 73

Forecast Period: 2026 - 2033

Market Size: $13000 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 73

Forecast Period: 2026 - 2033

Market Size: $13000 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Eliquis Market Overview

The Eliquis market refers to the global industry for the anticoagulant medication Eliquis, which is used to prevent blood clots and stroke. As a crucial segment of the pharmaceutical industry, the Eliquis market size is estimated to be around $18.7 billion in 2025. The growth outlook for the Eliquis market is promising, with a market forecast that indicates a compound annual growth rate (CAGR) of 11.2% from 2026 to 2033, driven by factors such as an increasing prevalence of atrial fibrillation and a growing demand for effective anticoagulants. The scope of the industry expansion encompasses various regions, including North America, Europe, Asia-Pacific, and Latin America, with a focus on novel oral anticoagulants and cardiovascular disease management.

Loading chart…

The growth of the Eliquis market is driven by key forces such as technology shifts towards novel oral anticoagulants, regulations supporting the use of Eliquis, and consumer behavior favoring convenient and effective treatments. The largest region for the Eliquis market is North America, while the fastest-growing region is Asia-Pacific. With a strong growth forecast and a promising market size, the Eliquis market is expected to experience significant industry expansion over the forecast period, driven by an increasing demand for effective anticoagulants and a growing awareness of cardiovascular disease management.

Report Overview

Report Attribute	Details
Market size value in 2025	13.00 billion
Revenue forecast in 2033	28.27 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Pfizer; Bristol Myers Squibb
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Eliquis market is poised for significant growth, driven by an increasing demand for effective anticoagulants. As the Eliquis market size continues to expand, it is essential to understand the underlying dynamics driving this growth.

Growth Drivers2 items

The rising prevalence of atrial fibrillation and deep vein thrombosis is expected to fuel the growth of the Eliquis market, as these conditions often require anticoagulant therapy.

Advances in medical technology and pharmaceutical research are leading to the development of more effective and safer anticoagulants, such as Eliquis, which is contributing to the growth forecast of the market.

Restraints2 items

The high cost of Eliquis and other novel oral anticoagulants is a significant barrier to adoption, particularly in emerging markets where healthcare budgets are limited.

The presence of generic anticoagulants in the market is also expected to restrain the growth of the Eliquis market, as these alternatives are often significantly cheaper.

Opportunities2 items

The increasing awareness of the benefits of Eliquis and other novel oral anticoagulants among patients and prescribers is creating new opportunities for growth in the market.

The expanding geriatric population and the associated increase in age-related diseases, such as stroke and cardiovascular disease, are also expected to drive demand for Eliquis and contribute to the Eliquis market size.

Challenges2 items

The Eliquis market is highly competitive, with several established players and new entrants competing for market share, which can make it challenging for companies to differentiate their products and maintain profitability.

The regulatory environment for anticoagulants is also evolving, with stringent safety and efficacy requirements, which can pose challenges for companies seeking to develop and commercialize new products, including those in the growth forecast for the Eliquis market.

Market Segmentation

Loading chart…

The Eliquis market can be segmented by type, which includes subtypes such as factor Xa inhibitors. This segmentation contributes to the overall Eliquis market size by providing a clear understanding of the different types of products available in the market. Understanding the Eliquis segmentation by type is crucial for industry players to develop targeted strategies and products that cater to specific needs.

The application segment of the Eliquis market includes subtypes such as stroke prevention and treatment of deep vein thrombosis. This segmentation is critical in understanding the Eliquis market taxonomy, as it highlights the various uses of Eliquis in different medical conditions. By analyzing the application segment, industry players can identify areas of growth and develop strategies to increase their market share.

Eliquis Segmentation Breakdown9 items

Type

2.5 mg

5 mg

World Eliquis Production

Application

Deep Vein Thrombosis (DVT)

Pulmonary Embolism (PE)

Others

World Eliquis Production

Regional Insights

Loading chart…

The Eliquis market growth is anticipated to be driven by various factors across different regions. In terms of regional forecast, North America is expected to be the largest region, accounting for approximately 40% of the market share, driven by high adoption rates, favorable policies, and significant investments in the healthcare sector. On the other hand, the Asia Pacific region is projected to be the fastest-growing region, driven by increasing demand, improving infrastructure, and a growing ecosystem maturity.

Key drivers for each region include: for North America, high adoption rates, favorable policies, and significant investments; for Europe, established infrastructure, growing demand, and increasing awareness; for Asia Pacific, improving infrastructure, growing ecosystem maturity, and increasing investments; for Latin America, growing demand, improving adoption rates, and increasing government support; and for Middle East & Africa, growing awareness, improving infrastructure, and increasing investments. These factors are expected to contribute to the regional forecast and Eliquis market growth.

Competitive Landscape

The Eliquis market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Eliquis competitive landscape is characterized by high competition, with key players employing various strategies to differentiate themselves. Global players tend to dominate the market, leveraging their extensive resources and distribution networks to maintain their position.

Companies in the Eliquis market employ common strategies such as M&A, partnerships, product launches, expansion, R&D, and localization to stay competitive. However, they face challenges like margin pressure, compliance costs, and commoditization, which can erode their competitive advantage. To differentiate themselves, companies focus on technology, service model, channel strength, customization, and cost advantages. The following companies have notable strategic focuses:

Pfizer: regional expansion

Bristol Myers Squibb: innovation pipeline

Pfizer: premium pricing

Bristol Myers Squibb: local manufacturing

Pfizer: OEM tie-ups

Bristol Myers Squibb: vertical integration

Key Eliquis Companies2 items

Pfizer

Bristol Myers Squibb

Market Ecosystem

The Eliquis ecosystem spans upstream, midstream, and downstream activities, encompassing technology providers, integrators, channels, and end users. This ecosystem is characterized by the creation and capture of value through the development, manufacturing, and distribution of Eliquis, a medication used to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation. The ecosystem boundaries are defined by the interactions among various participants, including suppliers, manufacturers, distributors, and end users, who collectively contribute to the delivery of Eliquis to patients.

Raw material suppliers — provide active pharmaceutical ingredients

OEMs / manufacturers — produce Eliquis medication

Distributors / channel partners — deliver Eliquis to healthcare providers

Service providers / after-sales — offer patient support and education

End users / buyers — patients and healthcare providers

Regulators/standards bodies — oversee approval and compliance

Data/analytics providers — support market research and analysis

In the Eliquis ecosystem, control points are primarily held by regulators and manufacturers, who influence adoption through approvals, pricing, and distribution strategies. Dependency risks arise from input constraints, such as supplier shortages, and standards, like regulatory requirements. Switching costs are relatively high due to the complexity of pharmaceutical manufacturing and distribution. As part of a comprehensive value chain analysis, understanding these dynamics is essential to navigating the Eliquis ecosystem, which may differ by region due to varying regulatory environments and market conditions.

Recent Industry Insights

The Eliquis industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between pharmaceutical companies and research institutions, have driven innovation in the Eliquis market. Notable mergers and acquisitions have also taken place, leading to market consolidation and increased competition. Furthermore, product launches and technological advancements have expanded treatment options for patients, while regulatory changes have impacted the market landscape. A shift in consumer trends towards preventive care has also been observed, driving demand for Eliquis and similar products. Additionally, funding rounds and expansions have enabled companies to invest in research and development, paving the way for future growth in the Eliquis market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Eliquis market outlook. The market attractiveness is moderate, driven by the growing demand for anticoagulant therapies. The competitive intensity is high, with several key players vying for market share. The long-term outlook is positive, with increasing adoption of Eliquis in various indications.

The innovation landscape is evolving, with ongoing research focused on improving patient outcomes and reducing bleeding risks. The demand-supply balance is stable, with manufacturers ensuring adequate supply to meet growing demand. Key risk factors include intense competition, regulatory changes, and potential safety concerns. Overall, the Eliquis market is expected to experience steady growth, driven by its efficacy and expanding indications.

12 items

1. Executive Summary

2. Eliquis Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Eliquis Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Eliquis Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Eliquis Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Eliquis Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Eliquis Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Eliquis Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Eliquis Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Eliquis Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Eliquis Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Eliquis Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Eliquis Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Eliquis Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Eliquis Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Eliquis Market Competition by Key Manufacturers

9.1. Global Eliquis Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Eliquis: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Pfizer

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Bristol Myers Squibb

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Eliquis Market

Figure 4: Global Eliquis Market: Drivers

Figure 5: Global Eliquis Market: Challenges

Figure 6: Global Eliquis Market: Trends

Figure 7: Global Eliquis Market: Opportunity

Figure 8: Global Eliquis Market: Restraint

Figure 9: Global Eliquis Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Eliquis Market Value (USD Million) By Region

Figure 19: Global Eliquis Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Eliquis Market Value (USD Million) By Region

Figure 27: Global Eliquis Market Share (%) By: Regions (2032)

Figure 28: Global Eliquis Market Volume (K) By Region

Figure 29: Global Eliquis Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Eliquis Market Value (USD Million) By Region

Figure 37: Global Eliquis Market Share (%) By: Regions (2032)

Figure 38: Global Eliquis Market Volume (K) By Region

Figure 39: Global Eliquis Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

99 items

Table 1: Market Segmentation Analysis

Table 2: Global Eliquis Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Eliquis Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Eliquis Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Eliquis Market Value (USD Million) By Region

Table 14: Global Eliquis Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Eliquis Market Volume (K) By Region

Table 31: Global Eliquis Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Eliquis Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Eliquis Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Eliquis Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Pfizer Basic Information And Sales Area

Table 52: Pfizer. Products Portfolio

Table 53: Bristol Myers Squibb Basic Information And Sales Area

Table 54: Bristol Myers Squibb. Products Portfolio

Table 55: Global Market Value (USD Million) (2025-2032) By Type

Table 56: Global Market Share (%) By Type (2032)

Table 57: Global Market Value (USD Million) (2025-2032) By Application

Table 58: Global Market Share (%) By Application (2032)

Table 59: Global Market Volume (K) (2025-2032) By Type

Table 60: Global Market Share (%) By Type (2032)

Table 61: Global Market Volume (K) (2025-2032) By Application

Table 62: Global Market Share (%) By Application (2032)

Table 63: Global Eliquis Market Value (USD Million) By Region

Table 64: Global Eliquis Market Share (%) By Region (2025-2032)

Table 65: North America Market Value (USD Million) (2025-2032) By Country

Table 66: North America Market Value (USD Million) (2025-2032) By Type

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: Europe Market Value (USD Million) (2025-2032) By Country

Table 69: Europe Market Value (USD Million) (2025-2032) By Type

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: South America Market Value (USD Million) (2025-2032) By Country

Table 75: South America Market Value (USD Million) (2025-2032) By Type

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Global Eliquis Market Volume (K) By Region

Table 81: Global Eliquis Market Share (%) By Region (2025-2032)

Table 82: North America Market Volume (K) (2025-2032) By Country

Table 83: North America Market Volume (K) (2025-2032) By Type

Table 84: North America Market Volume (K) (2025-2032) By Application

Table 85: Europe Market Volume (K) (2025-2032) By Country

Table 86: Europe Market Volume (K) (2025-2032) By Type

Table 87: Europe Market Volume (K) (2025-2032) By Application

Table 88: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 89: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 90: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 91: South America Market Volume (K) (2025-2032) By Country

Table 92: South America Market Volume (K) (2025-2032) By Type

Table 93: South America Market Volume (K) (2025-2032) By Application

Table 94: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 95: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 96: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 97: Research Programs/Design For This Report

Table 98: Key Data Information From Secondary Sources

Table 99: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Eliquis Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	13.00 billion
Revenue forecast in 2033	28.27 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Pfizer; Bristol Myers Squibb
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options